MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Helen of Troy Limited EBITDA 2011-2026 | HELE
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA Helen of Troy Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 198 M | 312 M | 256 M | 308 M | 319 M | 216 M | 229 M | 203 M | 206 M | 151 M | 201 M | 151 M | 183 M | 170 M | 130 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 319 M | 130 M | 216 M |
Quarterly EBITDA Helen of Troy Limited
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.67 M | -312 M | -393 M | - | 79.6 M | 39.4 M | 44.6 M | - | 119 M | 60.7 M | 51.4 M | - | 88.9 M | 58.1 M | 44.4 M | - | 98.7 M | 248 M | 150 M | 73.5 M | 110 M | 110 M | 109 M | 66.1 M | 88 M | 88 M | 62.9 M | 55 M | 68.5 M | 68.5 M | 58 M | - | 75.7 M | 48.1 M | 38.9 M | - | 74.5 M | 157 M | 82.5 M | - | 66.4 M | 147 M | 80.2 M | 36.9 M | 75.6 M | 142 M | 66.2 M | - | 58.1 M | 126 M | 67.4 M | - | 55.8 M | 136 M | 79.8 M | - | 49.2 M | 124 M | 74.7 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 248 M | -393 M | 65.1 M |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Household products industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Natura &Co Holding S.A.
NTCO
|
1.12 B | - | - | $ 9.02 B | - |
 |
LifeVantage Corporation
LFVN
|
15.4 M | $ 4.48 | -1.32 % | $ 54.9 M |  USA |
 |
The Clorox Company
CLX
|
219 M | $ 104.78 | -1.04 % | $ 12.9 B | USA |
 |
Mannatech, Incorporated
MTEX
|
664 K | $ 6.86 | - | $ 12.8 M | USA |
 |
Nature's Sunshine Products
NATR
|
38.6 M | $ 23.02 | -2.56 % | $ 414 M | USA |
 |
Edgewell Personal Care Company
EPC
|
287 M | $ 19.25 | -1.31 % | $ 957 M | USA |
 |
Nu Skin Enterprises
NUS
|
118 M | $ 7.14 | -0.76 % | $ 352 M | USA |
 |
Inter Parfums
IPAR
|
296 M | $ 90.53 | -0.18 % | $ 2.91 B | USA |
 |
Unilever PLC
UL
|
10.5 B | $ 60.74 | -0.57 % | $ 132 B |  Britain |
 |
Kimberly-Clark Corporation
KMB
|
3.16 B | $ 99.15 | -0.3 % | $ 32.9 B | USA |
 |
The Procter & Gamble Company
PG
|
23.3 B | $ 143.66 | -0.23 % | $ 338 B | USA |
 |
Newell Brands
NWL
|
350 M | $ 3.52 | -1.82 % | $ 1.47 B | USA |
 |
Coty
COTY
|
661 M | $ 2.1 | -1.18 % | $ 1.83 B | USA |
 |
Church & Dwight Co.
CHD
|
1.32 B | $ 93.95 | -0.74 % | $ 22.8 B | USA |
 |
Colgate-Palmolive Company
CL
|
3.94 B | $ 84.79 | -0.42 % | $ 68.6 B | USA |
 |
The Estée Lauder Companies
EL
|
44 M | $ 73.46 | -7.34 % | $ 26.5 B | USA |
 |
e.l.f. Beauty
ELF
|
186 M | $ 70.5 | -1.97 % | $ 3.86 B | USA |
 |
Spectrum Brands Holdings
SPB
|
223 M | $ 72.1 | -0.78 % | $ 1.85 B | USA |
 |
Hims & Hers Health
HIMS
|
160 M | $ 22.16 | -1.55 % | $ 4.99 B | USA |
 |
United-Guardian
UG
|
2.97 M | $ 6.25 | -0.32 % | $ 28.7 M | USA |
 |
USANA Health Sciences
USNA
|
70 M | $ 17.13 | -2.34 % | $ 318 M | USA |
 |
Dogness (International) Corporation
DOGZ
|
3.53 M | $ 1.49 | -1.97 % | $ 50.2 M |  China |
 |
Revlon
REV
|
229 M | - | -4.41 % | $ 212 M | USA |
 |
Acme United Corporation
ACU
|
21.1 M | $ 45.0 | -1.08 % | $ 170 M | USA |